Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de México, S.A. de C.V. becoming a wholly-owned subsidiary of the company.
Minister was briefed on the nationwide dengue situation
Kivo’s expanded platform brings compliant collaboration and intelligent process automation to emerging Regulatory, Clinical and Quality teams
Commenced operations in flood-affected Himachal Pradesh
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
30 beneficiaries avail of services per minute
Research released at UN General Assembly week shows tests predicting heart disease and diabetes are among lowest cost solutions for improving Indian health
The state of the healthcare services will improve substantially with the involvement and participation of ULBs
The company's Bavla site was successfully jointly inspected by the EDQM and Italian Medicines Agency (AIFA)
Subscribe To Our Newsletter & Stay Updated
